Biblio
[Clinical features and risk factors for invasive fungal sinusitis after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2024;45(1):22-27.
[Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2024;45(1):18-21.
. [The effect of glucose-6-phosphate dehydrogenase deficiency on allogeneic hematopoietic stem cell transplantation in patients with hematological disorders]. Zhonghua Xue Ye Xue Za Zhi. 2024;45(2):121-127.
[Effect of sirolimus combined with anti-CD20 monoclonal antibody desensitization on the prognosis of patients underwent haploidentical stem cell transplantation]. Zhonghua Yi Xue Za Zhi. 2024;104(11):843-849.
[Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(12):1027-1031.
[Clinical analysis of sirolimus as an alternative GVHD prophylaxis for patients with kidney injury undergoing allo-HSCT]. Zhonghua Nei Ke Za Zhi. 2023;62(12):1444-1450.
[Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation]. Zhonghua Nei Ke Za Zhi. 2023;62(1):76-83.
. [Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation]. Zhonghua Nei Ke Za Zhi. 2023;62(7):826-832.
[Clinical characteristics of patients with human adenovirus infection undergoing allogeneic hematopoietic stem cell transplantation]. Zhonghua Nei Ke Za Zhi. 2023;62(2):163-168.
Connexin 43 gap junction affects survival and drug resistance of multiple myeloma side population cells. J Physiol Pharmacol. 2023;74(3).
. [Dynamic monitoring of plasma Epstein-Barr Virus DNA load can predict the occurrence of lymphoproliferative disorders after haploidentical hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(4):284-288.
. [Impact of SARS-CoV-2 infection on graft composition and early transplant outcomes following allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(11):890-899.
[Incidence and clinical characteristics of engraftment syndrome after syngeneic hematopoietic stem cell transplantation in patients with hematological diseases]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(4):289-294.
. [Prognostic analysis of patients with acute leukemia and central nervous system involvement undergoing allogeneic hematopoietic stem cell transplantation]. Zhonghua Nei Ke Za Zhi. 2023;62(11):1295-1302.
[Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(2):124-131.
[Dynamic assessment of WT1 for predicting the relapse of acute myeloid leukemia patients with MLL rearrangements after hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2022;43(9):785-787.
[Incidence and clinical significance of platelet transfusion refractoriness after allogeneic hematopoietic stem cell transplantation in patients with chronic myelomonocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2022;43(9):738-744.
. [Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation]. Beijing Da Xue Xue Bao Yi Xue Ban. 2022;54(5):1013-1020.
[Safety of rabbit anti-human thymocyte immunoglobulin in second allogeneic hematopoietic stem cell transplantation for patients with hematological diseases]. Zhonghua Xue Ye Xue Za Zhi. 2022;43(10):853-857.
[BK virus encephalitis in children with hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2021;42(10):823-827.
[The effect of donor cytomegalovirus serological status on the outcome of allogeneic stem cell transplantation]. Zhonghua Nei Ke Za Zhi. 2021;60(5):459-465.
[Risk factors analysis for steroid-resistant acute graft versus host disease after haploidentical hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(2):106-111.
[Minimal residual disease in adults with Philadelphia chromosome negative acute lymphoblastic leukemia in high-risk]. Zhonghua Xue Ye Xue Za Zhi. 2019;40(7):554-560.
[Clinical implication of minimal residue disease monitoring by WT1 gene detection and flow cytometry in myelodysplastic syndrome with allogeneic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2018;39(12):998-1003.
.